Reaktion #2383757

ord-f47efb53f0904d7b8e0960181b74a167

Reaktionsbedingungen

Detaillierte Bedingungen
See reaction.notes.procedure_details.

Aufarbeitung

  1. 1
    Sonstigeat 5° C.
  2. 2
    workup.ADDITIONAfter addition
  3. 3
    Sonstigewas separated
  4. 4
    Waschenthe aqueous phase washed with an additional portion of ethyl acetate
  5. 5
    Extraktionthe product extracted into several portions of fresh ethyl acetate
  6. 6
    Waschenback-washed with water
  7. 7
    Waschenwashed with brine
  8. 8
    Trocknendried over anhydrous magnesium sulfate
  9. 9
    Sonstigeevaporated to dryness in vacuo
  10. 10
    Sonstigethe residue crystallized from methylene chloride

Vorschrift

Cephalexin (696 mg., 2 mmoles) was dissolved in 10 ml. of water at 5° C. by the action of potassium carbonate (304 mg., 2.2 mmoles). Ethyl acetate (5 ml.) was added and then 4-ethyl-2,3-dioxopiperazine-1-carbonyl chloride (450 mg., 2.2 mole) was added over a period of 15 minutes at 0°-5° C. After addition was complete, the reaction mixture was stirred for an additional 30 minutes, at which time the ethyl acetate layer was separated and the aqueous phase washed with an additional portion of ethyl acetate. The aqueous phase was adjusted to 2.5 and the product extracted into several portions of fresh ethyl acetate. The acidic ethyl acetate extracts were combined, back-washed with water, washed with brine, dried over anhydrous magnesium sulfate, evaporated to dryness in vacuo, and the residue crystallized from methylene chloride to yield 3-methyl-7-[2-phenyl-2-(4-ethyl-2,3-dioxopiperazine-1-carboxamido)acetamido]ceph-3-em-4-carboxylic acid (568 mg., m.p. 199°-200° C.).

Quelle

DOI: 10.6084/m9.figshare.5104873.v1Patent: US04429128uspto-grants-1984_01